The Influenza Virus Enigma

Cell

Volumn 136, Issue 3, 2009, Pages 402-410

  Salomon, Rachelle ^a   Webster, Robert G ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAS 181; FLUDASE; INFLUENZA VACCINE; OSELTAMIVIR; RIBAVIRIN; SIALIDASE; TARIBAVIRIN; UNCLASSIFIED DRUG; ZANAMIVIR;

DRUG INHIBITION; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VIRUS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VACCINATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

AVIAN INFLUENZA VIRUS; ORTHOMYXOVIRIDAE;

EID: 59049093098     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2009.01.029     Document Type: Review

References (70)

1. Alexander D.J. An overview of the epidemiology of avian influenza. Vaccine 25 (2007) 5637-5644
2. Beigel J.H., Farrar J., Han A.M., Hayden F.G., Hyer R., de Jong M.D., Lochindarat S., Nguyen T.K., Nguyen T.H., Tran T.H., et al. Avian influenza A (H5N1) infection in humans. N. Engl. J. Med. 353 (2005) 1374-1385
3. Belser J.A., Lu X., Szretter K.J., Jin X., Aschenbrenner L.M., Lee A., Hawley S., Kim do H., Malakhov M.P., Yu M., et al. DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection. J. Infect. Dis. 196 (2007) 1493-1499
4. Budd A., Alleva L., Alsharifi M., Koskinen A., Smythe V., Mullbacher A., Wood J., and Clark I. Increased survival after gemfibrozil treatment of severe mouse influenza. Antimicrob. Agents Chemother. 51 (2007) 2965-2968
5. Cameron C.M., Cameron M.J., Bermejo-Martin J.F., Ran L., Xu L., Turner P.V., Ran R., Danesh A., Fang Y., Chan P.K., et al. Gene expression analysis of host innate immune responses during lethal H5N1 infection in ferrets. J. Virol. 82 (2008) 11308-11317
6. Chan M.C., Cheung C.Y., Chui W.H., Tsao S.W., Nicholls J.M., Chan Y.O., Chan R.W., Long H.T., Poon L.L., Guan Y., et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir. Res. 6 (2005) 135
7. Cheung C.Y., Poon L.L., Lau A.S., Luk W., Lau Y.L., Shortridge K.F., Gordon S., Guan Y., and Peiris J.S. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?. Lancet 360 (2002) 1831-1837
8. Das K., Ma L.C., Xiao R., Radvansky B., Aramini J., Zhao L., Marklund J., Kuo R.L., Twu K.Y., Arnold E., et al. Structural basis for suppression of a host antiviral response by influenza A virus. Proc. Natl. Acad. Sci. USA 105 (2008) 13093-13098
9. de Jong M.D., Simmons C.P., Thanh T.T., Hien V.M., Smith G.J., Chau T.N., Hoang D.M., Chau N.V., Khanh T.H., Dong V.C., et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12 (2006) 1203-1207
10. Dugan V.G., Chen R., Spiro D.J., Sengamalay N., Zaborsky J., Ghedin E., Nolting J., Swayne D.E., Runstadler J.A., Happ G.M., et al. The evolutionary genetics and emergence of avian influenza viruses in wild birds. PLoS Pathog. 4 (2008) e1000076 10.1371/journal.ppat.1000076
11. Fedson D.S. Pandemic influenza: a potential role for statins in treatment and prophylaxis. Clin. Infect. Dis. 43 (2006) 199-205
12. Fouchier R.A., Osterhaus A.D., and Brown I.H. Animal influenza virus surveillance. Vaccine 21 (2003) 1754-1757
13. Gabriel G., Dauber B., Wolff T., Planz O., Klenk H.D., and Stech J. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc. Natl. Acad. Sci. USA 102 (2005) 18590-18595
14. Govorkova E.A., Webby R.J., Humberd J., Seiler J.P., and Webster R.G. Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge. J. Infect. Dis. 194 (2006) 159-167
15. Govorkova E.A., Ilyushina N.A., Boltz D.A., Douglas A., Yilmaz N., and Webster R.G. Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus. Antimicrob. Agents Chemother. 51 (2007) 1414-1424
16. Hanson B.J., Boon A.C., Lim A.P., Webb A., Ooi E.E., and Webby R.J. Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice. Respir. Res. 7 (2006) 126
17. Hao L., Sakurai A., Watanabe T., Sorensen E., Nidom C.A., Newton M.A., Ahlquist P., and Kawaoka Y. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 454 (2008) 890-893
18. Hatta M., Gao P., Halfmann P., and Kawaoka Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293 (2001) 1840-1842
19. Hayden F.G. Antiviral resistance in influenza viruses-implications for management and pandemic response. N. Engl. J. Med. 354 (2006) 785-788
20. He X., Zhou J., Bartlam M., Zhang R., Ma J., Lou Z., Li X., Li J., Joachimiak A., Zeng Z., et al. Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus. Nature 454 (2008) 1123-1126
21. Hulse D.J., Sturm-Ramirez K.M., Humbred J., Seiler P., Govorkova E.A., Krauss S., Scholtissek C., Puthavathana P., Buranathai C., Nguyen T.D., et al. Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc. Natl. Acad. Sci. USA 102 (2005) 10682-10687
22. Ito T. Interspecies transmission and receptor recognition of influenza A viruses. Microbiol. Immunol. 44 (2000) 423-430
23. Kash J.C., Goodman A.G., Korth M.J., and Katze M.G. Hijacking of the host-cell response and translational control during influenza virus infection. Virus Res. 119 (2006) 111-120
24. Kash J.C., Tumpey T.M., Proll S.C., Carter V., Perwitasari O., Thomas M.J., Basler C.F., Palese P., Taubenberger J.K., Garcia-Sastre A., et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443 (2006) 578-581
25. Kilpatrick A.M., Chmura A.A., Gibbons D.W., Fleischer R.C., Marra P.P., and Daszak P. Predicting the global spread of H5N1 avian influenza. Proc. Natl. Acad. Sci. USA 103 (2006) 19368-19373
26. Kobasa D., Takada A., Shinya K., Hatta M., Halfmann P., Theriault S., Suzuki H., Nishimura H., Mitamura K., Sugaya N., et al. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 431 (2004) 703-707
27. Lackenby, A., Hungnes, O., Dudman, S.G., Meijer, A., Paget, W.J., Hay, A.J., and Zambon, M.C. (2008). Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. Eurosurveillance 13. http://www.eurosurveillance.org/edition/v13n05/080131_080132.asp.
28. Le Q.M., Kiso M., Someya K., Sakai Y.T., Nguyen T.H., Nguyen K.H., Pham N.D., Ngyen H.H., Yamada S., Muramoto Y., et al. Avian flu: isolation of drug-resistant H5N1 virus. Nature 437 (2005) 1108
29. Leroux-Roels I., Borkowski A., Vanwolleghem T., Drame M., Clement F., Hons E., Devaster J.M., and Leroux-Roels G. Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. Lancet 370 (2007) 580-589
30. Li K.S., Guan Y., Wang J., Smith G.J., Xu K.M., Duan L., Rahardjo A.P., Puthavathana P., Buranathai C., Nguyen T.D., et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 430 (2004) 209-213
31. Lowen A.C., Mubareka S., Steel J., and Palese P. Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog. 3 (2007) e151 10.1371/journal.ppat.0030151
32. Ludwig S., Stitz L., Planz O., Van H., Fitch W.M., and Scholtissek C. European swine virus as a possible source for the next influenza pandemic?. Virology 212 (1995) 555-561
33. Ludwig S., Pleschka S., Planz O., and Wolff T. Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells. Cell. Microbiol. 8 (2006) 375-386
34. Ma W., Vincent A.L., Gramer M.R., Brockwell C.B., Lager K.M., Janke B.H., Gauger P.C., Patnayak D.P., Webby R.J., and Richt J.A. Identification of H2N3 influenza A viruses from swine in the United States. Proc. Natl. Acad. Sci. USA 104 (2007) 20949-20954
35. Maines T.R., Chen L.M., Matsuoka Y., Chen H., Rowe T., Ortin J., Falcon A., Nguyen T.H., Mai le Q., Sedyaningsih E.R., et al. Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc. Natl. Acad. Sci. USA 103 (2006) 12121-12126
36. Matrosovich M., Zhou N., Kawaoka Y., and Webster R. The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J. Virol. 73 (1999) 1146-1155
37. Matrosovich M.N., Matrosovich T.Y., Gray T., Roberts N.A., and Klenk H.D. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Natl. Acad. Sci. USA 101 (2004) 4620-4624
38. McCullers J.A. Insights into the interaction between influenza virus and pneumococcus. Clin. Microbiol. Rev. 19 (2006) 571-582
39. Monto A.S., McKimm-Breschkin J.L., Macken C., Hampson A.W., Hay A., Klimov A., Tashiro M., Webster R.G., Aymard M., Hayden F.G., et al. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob. Agents Chemother. 50 (2006) 2395-2402
40. Morens D.M., Taubenberger J.K., and Fauci A.S. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J. Infect. Dis. 198 (2008) 962-970
41. Nicholls J.M., Chan M.C., Chan W.Y., Wong H.K., Cheung C.Y., Kwong D.L., Wong M.P., Chui W.H., Poon L.L., Tsao S.W., et al. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat. Med. 13 (2007) 147-149
42. Noda T., Sagara H., Yen A., Takada A., Kida H., Cheng R.H., and Kawaoka Y. Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature 439 (2006) 490-492
43. Obenauer J.C., Denson J., Mehta P.K., Su X., Mukatira S., Finkelstein D.B., Xu X., Wang J., Ma J., Fan Y., et al. Large-scale sequence analysis of avian influenza isolates. Science 311 (2006) 1576-1580
44. Peiris J.S., de Jong M.D., and Guan Y. Avian influenza virus (H5N1): a threat to human health. Clin. Microbiol. Rev. 20 (2007) 243-267
45. Perez D.R., Lim W., Seiler J.P., Yi G., Peiris M., Shortridge K.F., and Webster R.G. Role of quail in the interspecies transmission of H9 influenza A viruses: molecular changes on HA that correspond to adaptation from ducks to chickens. J. Virol. 77 (2003) 3148-3156
46. Pichlmair A., Schulz O., Tan C.P., Naslund T.I., Liljestrom P., Weber F., and Reis e Sousa C. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314 (2006) 997-1001
47. Rimmelzwaan G.F., van Riel D., Baars M., Bestebroer T.M., van Amerongen G., Fouchier R.A., Osterhaus A.D., and Kuiken T. Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. Am. J. Pathol. 168 (2006) 176-183
48. Rimmelzwaan G.F., Fouchier R.A., and Osterhaus A.D. Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development. Curr. Opin. Biotechnol. 18 (2007) 529-536
49. Salomon R., Franks J., Govorkova E.A., Ilyushina N.A., Yen H.L., Hulse-Post D.J., Humberd J., Trichet M., Rehg J.E., Webby R.J., et al. The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. J. Exp. Med. 203 (2006) 689-697
50. Salomon R., Hoffmann E., and Webster R.G. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc. Natl. Acad. Sci. USA 104 (2007) 12479-12481
51. Shinya K., Ebina M., Yamada S., Ono M., Kasai N., and Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature 440 (2006) 435-436
52. Simmons C.P., Bernasconi N.L., Suguitan A.L., Mills K., Ward J.M., Chau N.V., Hien T.T., Sallusto F., Ha do Q., Farrar J., et al. Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza. PLoS Med. 4 (2007) e178 10.1371/journal.pmed.0040178
53. Smith G.J., Fan X.H., Wang J., Li K.S., Qin K., Zhang J.X., Vijaykrishna D., Cheung C.L., Huang K., Rayner J.M., et al. Emergence and predominance of an H5N1 influenza variant in China. Proc. Natl. Acad. Sci. USA 103 (2006) 16936-16941
54. Songserm T., Amonsin A., Jam-on R., Sae-Heng N., Pariyothorn N., Payungporn S., Theamboonlers A., Chutinimitkul S., Thanawongnuwech R., and Poovorawan Y. Fatal avian influenza A H5N1 in a dog. Emerg. Infect. Dis. 12 (2006) 1744-1747
55. Stevens J., Blixt O., Glaser L., Taubenberger J.K., Palese P., Paulson J.C., and Wilson I.A. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J. Mol. Biol. 355 (2006) 1143-1155
56. Stevens J., Blixt O., Tumpey T.M., Taubenberger J.K., Paulson J.C., and Wilson I.A. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312 (2006) 404-410
57. Subbarao K., and Joseph T. Scientific barriers to developing vaccines against avian influenza viruses. Nat. Rev. Immunol. 7 (2007) 267-278
58. Subbarao E.K., London W., and Murphy B.R. A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J. Virol. 67 (1993) 1761-1764
59. Swayne D.E. Understanding the complex pathobiology of high pathogenicity avian influenza viruses in birds. Avian Dis. 51 (2007) 242-249
60. Szretter K.J., Gangappa S., Lu X., Smith C., Shieh W.J., Zaki S.R., Sambhara S., Tumpey T.M., and Katz J.M. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J. Virol. 81 (2007) 2736-2744
61. Tompkins S.M., Lo C.Y., Tumpey T.M., and Epstein S.L. Protection against lethal influenza virus challenge by RNA interference in vivo. Proc. Natl. Acad. Sci. USA 101 (2004) 8682-8686
62. Tumpey T.M., Szretter K.J., Van Hoeven N., Katz J.M., Kochs G., Haller O., Garcia-Sastre A., and Staeheli P. The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. J. Virol. 81 (2007) 10818-10821
63. van Riel D., Munster V.J., de Wit E., Rimmelzwaan G.F., Fouchier R.A., Osterhaus A.D., and Kuiken T. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am. J. Pathol. 171 (2007) 1215-1223
64. Wang J., Vijaykrishna D., Duan L., Bahl J., Zhang J.X., Webster R.G., Peiris J.S., Chen H., Smith G.J., and Guan Y. Identification of the progenitors of Indonesia and Vietnam avian influenza A (H5N1) viruses from southern China. J. Virol. 82 (2008) 3405-3414
65. Wang M., Lamberth K., Harndahl M., Roder G., Stryhn A., Larsen M.V., Nielsen M., Lundegaard C., Tang S.T., Dziegiel M.H., et al. CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening. Vaccine 25 (2007) 2823-2831
66. Watanabe T., Watanabe S., Kim J.H., Hatta M., and Kawaoka Y. A novel approach to the development of effective H5N1 influenza A virus vaccines: the use of M2 cytoplasmic tail mutants. J. Virol. 82 (2007) 2486-2492
67. Webster R.G. Wet markets-a continuing source of severe acute respiratory syndrome and influenza?. Lancet 363 (2004) 234-236
68. Yamada S., Suzuki Y., Suzuki T., Le M.Q., Nidom C.A., Sakai-Tagawa Y., Muramoto Y., Ito M., Kiso M., Horimoto T., et al. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 444 (2006) 378-382
69. Yen H.L., Ilyushina N.A., Salomon R., Hoffmann E., Webster R.G., and Govorkova E.A. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo. J. Virol. 81 (2007) 12418-12426
70. Yen H.L., Lipatov A.S., Ilyushina N.A., Govorkova E.A., Franks J., Yilmaz N., Douglas A., Hay A., Krauss S., Rehg J.E., et al. Inefficient transmission of H5N1 influenza viruses in a ferret contact model. J. Virol. 81 (2007) 6890-6898